🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Très fier de Simon Gagnon qui contribue énormement au Projet Laurent et à l'avancement des traitements contre la giardiose. Merci aux codirecteurs Melanie Dieude et David Langlais, ainsi qu'au reste de l'équipe ! Merci à Boehringer Ingelheim pour le financement ! fmv.umontreal.ca/index.php?id=3…

So proud of Simon Gagnon You rock!!! #TeamGiardia

Do you want to work with EVs and DNA-seq in #Leishmania or other protozoan parasites? This could be useful: Identification and analysis of the DNA content of small extracellular vesicles isolated from Leishmania parasites - ScienceDirect sciencedirect.com/science/articl…

The paper is out :) Ana V. Ibarra-Meneses Atia B. Amin #GeorgeDong Martin Olivier David Langlais It is great to work with you all! STAR Protocols Cell Reports Cell Trends in Parasitology #extracellularvesicles #genomics #DNAseq #Leishmania

Very happy that our STAR Protocols paper is out! :)

Identification and analysis of the DNA content of small extracellular vesicles isolated from Leishmania parasites - a collaboration btw Ana V. Ibarra-Meneses Atia B. Amin @OlivierMcGil David Langlais Christopher Fernandez-Prada (He/Him) STAR Protocols #ASMicrobe hubs.li/Q01TFdMf0

We are ready for AMPS Symposium Host-Parasite Interactions #CPN2023

Great presentation by #AudreyCorbeil #CPN2023

Fantastic to hear about the impact of genotype and environment effect on the immune response in helminth infected mice! Fascinating work conducted by Dr. Loke and his team! Host-Parasite Interactions

i-NEVER REST: Investigating the role and impact of Nano-sized Extracellular VesiclEs and dRug RESisTance in protozoan diseases, has been approved for funding!!! Regev Rudzki WIS #NancyDuah David Langlais Martin Olivier #AnaClaudiaTorrecilhas #IgorAlmeida Ana V. Ibarra-Meneses #KwesiTandoh

🌟 PhD Opportunity Christopher Fernandez-Prada (He/Him) & David Langlais 🌟 Join our groundbreaking research on Leishmania’s EVs-Host Interactions! 🧬🔬 👉 Title: "DECODING THE CARGO" 📍 Fernandez-Prada's Lab & David Langlais' Lab 🔗 [Details in PDF] #PhDPosition #Research #ScienceJobs #Leishmania #EVs #AMR

You can read our latest paper :) A comment on: Extracellular Vesicles: Translational Agenda Questions for Three Protozoan Parasites. Published in Traffic - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/tr…

Amazing talk by Ana V. Ibarra-Meneses at #CPN2024 #Leishmania #AMR

…and we’re done !! #CPN2024 2nd Canadian Parasitology Network Symposium wraps up in Banff, AB. CPN_ Canadian Parasitology Network Host-Parasite Interactions @ucalgaryvetmed UCalgaryMedicine Microbiology, Immunology, and Infectious Diseases

After major revisions - resubmission - rejection - appeal - rebuttal - it is now finally out! Sure, this work had a lot of limitations, but the review process was a real effort. nature.com/articles/s4200…

A study of the cellular immunity of individuals co-infected with recurrent visceral leishmaniasis and HIV suggests that T cell unresponsiveness underlies visceral leishmaniasis chronicity NicklectedTropicalDiseases Institute of Tropical Medicine Antwerp NTDs @ ITM clinical sciences Kris Laukens Pieter Meysman Ana V. Ibarra-Meneses nature.com/articles/s4200…

Today the lab looks different! ☺️ Christopher Fernandez-Prada (He/Him)

🚨 New Paper Alert! 🚨 Check out our latest collaborative scoping review on the ecological determinants of the leishmaniasis vector, Lutzomyia spp. 🦟🌍 resjournals.onlinelibrary.wiley.com/doi/10.1111/mv… @KatieClow1 J Scott Weese Sydney 🧵(1/4)

📢 Our findings underscore the need for preventive measures to limit human & animal infections and raise awareness among at-risk populations. Read the full article here: journals.plos.org/plosone/articl… #OneHealth #Parasites #Research

Evaluation of the Leishmania Inositol Phosphorylceramide Synthase as a Drug Target Using a Chemical and Genetic Approach | ACS Infectious Diseases pubs.acs.org/doi/10.1021/ac…